Technical Analysis for RKV - Rakovina Therapeutics Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Death Cross | Bearish | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% |
| Alert | Time |
|---|---|
| 10 DMA Support | 3 days ago |
| 5x Volume Pace | 3 days ago |
| 3x Volume Pace | 3 days ago |
| 2x Volume Pace | 3 days ago |
| Down 5% | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-11-25
Rakovina Therapeutics, Inc., formerly Vincero Capital Corp., is a Canada-based company, which is engaged in developing cancer treatments based on DNA-damage response technologies. The Company’s lead product candidate is kt-2000 Next Generation PARP-inhibitors. Its pipeline includes kt-3000 Dual Action DDR-inhibitors and kt-4000 DNA Damaging DDR-inhibitors. Its kt-2000 series is a patented class of highly potent, oral inhibitors of poly (ADP-ribose) polymerase (PARP). Its kt-3000 drug candidates selectively inhibit secondary DDR pathways associated with treatment resistance and PARP. kt-4000 drug candidates release a potent DNA-damaging agent, while also inhibiting DDR to selectively kill cancer cells.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Catalysts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Catalysts
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.14 |
| 52 Week Low | 0.005 |
| Average Volume | 68,086 |
| 200-Day Moving Average | 0.089 |
| 50-Day Moving Average | 0.088 |
| 20-Day Moving Average | 0.084 |
| 10-Day Moving Average | 0.079 |
| Average True Range | 0.007 |
| RSI (14) | 46.24 |
| ADX | 21.23 |
| +DI | 16.563 |
| -DI | 24.688 |
| Chandelier Exit (Long, 3 ATRs) | 0.094 |
| Chandelier Exit (Short, 3 ATRs) | 0.091 |
| Upper Bollinger Bands | 0.101 |
| Lower Bollinger Band | 0.067 |
| Percent B (%b) | 0.39 |
| BandWidth | 41.289 |
| MACD Line | -0.003 |
| MACD Signal Line | -0.003 |
| MACD Histogram | 0.0001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.080 | ||||
| Resistance 3 (R3) | 0.080 | 0.080 | 0.080 | ||
| Resistance 2 (R2) | 0.080 | 0.080 | 0.080 | 0.080 | |
| Resistance 1 (R1) | 0.080 | 0.080 | 0.080 | 0.080 | 0.080 |
| Pivot Point | 0.080 | 0.080 | 0.080 | 0.080 | 0.080 |
| Support 1 (S1) | 0.080 | 0.080 | 0.080 | 0.080 | 0.080 |
| Support 2 (S2) | 0.080 | 0.080 | 0.080 | 0.080 | |
| Support 3 (S3) | 0.080 | 0.080 | 0.080 | ||
| Support 4 (S4) | 0.080 |
